PreAxia Health Care Payment Systems (PAXH) 10-K 1 Apr 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	31-May-13	Mar. 24, 2014	Nov. 30, 2011
Document And Entity Information	'	'	'
Entity Registrant Name	'PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.	'	'
Entity Central Index Key	'0001350156	'	'
Document Type	'10-K	'	'
Document Period End Date	31-May-13	'	'
Amendment Flag	'false	'	'
Current Fiscal Year End Date	'--05-31	'	'
Is Entity a Well-known Seasoned Issuer?	'No	'	'
Is Entity a Voluntary Filer?	'No	'	'
Is Entity's Reporting Status Current?	'No	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$4,241,035
Entity Common Stock, Shares Outstanding	'	17,652,082	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2013	'	'

Balance_Sheets

Balance Sheets (USD $)	31-May-13	31-May-12
Current Assets	'	'
Cash	$13,251	$8,468
Total Current Assets	13,251	8,468
Other Assets	'	'
Deposits	'	'
Intangible Software Costs	102,151	'
Total Other Assets	102,151	'
Total Assets	115,402	8,468
Current Liabilities	'	'
Accounts Payable and Accrued Liabilities	156,691	129,249
Accounts Payable and Accrued Liabilities – Related Party	817,094	627,525
Loan Payable	459,786	433,130
Accrued Interest – Loans Payable	8,992	5,326
Total Current Liabilities	1,442,563	1,195,230
STOCKHOLDERS’ DEFICIT	'	'
Capital stock	17,652	17,652
Stock Subscription Receivable	'	-170
Additional Paid-in Capital	1,705,628	1,620,797
Accumulated other Comprehensive Loss	-1,240	-1,545
Deficit Accumulated During the Development Stage	-3,049,201	-2,823,496
Total Stockholders’ Deficit	-1,327,161	-1,186,762
Total Liabilities and Stockholders’ Deficit	$115,402	$8,468

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	31-May-13	31-May-12
Statement of Financial Position [Abstract]	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	17,652,082	17,652,082

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended		64 Months Ended
	31-May-13	31-May-12	31-May-13
Operating Expenses	'	'	'
Consulting fees	$139,185	$120,000	$702,874
Professional fees	16,251	36,331	338,798
Office and administration	27,025	78,134	309,957
Research and development	'	240,596	1,256,546
Wages and benefits	39,260	65,282	299,805
Rent	4,392	18,541	55,858
Total Operating Expenses	226,113	558,884	2,963,838
Operating loss	-226,113	-558,884	-2,963,838
Commission income	'	47	47
Interest income	'	1	639
Interest expense	-3,664	-12,701	-62,453
Foreign currency transaction income (expense)	4,072	1,772	-23,596
Total Other Income (Expenses)	408	-10,881	-85,363
Net loss	-225,705	-569,765	-3,049,201
Foreign currency translation	305	978	-1,240
Comprehensive loss for the period	($225,400)	($568,787)	($3,050,441)
Basic and diluted loss per share	($0.01)	($0.03)	'
Weighted average number of shares outstanding	17,652,082	17,652,082	'

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended		64 Months Ended
	31-May-13	31-May-12	31-May-13
Cash Flows from Operating Activities	'	'	'
Net loss	($225,705)	($569,765)	($3,049,201)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Amortization of debt discount	'	'	28,495
Changes in operating assets and liabilities:	'	'	'
Decrease (increase) in trade receivables	'	'	4,300
Decrease (increase) in rent deposit	'	'	'
Increase (decrease) in accounts payable – related party	189,570	243,999	1,254,085
Increase (decrease) in accounts payable and accrued liabilities	27,445	-19,153	243,305
Increase (decrease) in accrued interest	3,662	12,701	38,607
Cash Flows used in operating activities	-5,028	-328,031	-1,480,409
Cash to Acquire Software	-102,151	'	-102,151
Cash Received from note receivable	'	'	49,281
Cash Acquired from business combination	'	'	86,692
Cash flows used in investing activities	-102,151	'	33,822
Cash Flows from Financing Activities	'	'	'
Overdraft in bank	'	-19,286	-4
Proceeds from loan payable – related party	26,656	6,960	146,459
Repayment of loan payable	'	'	-25,000
Proceeds from loan payable – Convertible Debenture	'	'	46,505
Proceeds from sale of common stock	85,001	344,999	1,284,542
Cash flows provided by financing activities	111,657	332,673	1,452,502
Effect of exchange rate changes on cash	305	6,809	7,337
Increase (decrease) in cash during the period	4,784	11,451	13,252
Cash, beginning of period	11,451	'	'
Cash, end of period	13,251	11,451	13,251
Non-Cash Investing and Financing Transactions:	'	'	'
Common stock issued for acquisition of subsidiary	'	'	12,000
Common stock issued for debt	'	'	$369,570

Shareholders_Equity

Shareholders Equity (USD $)	Common Stock	Additional Paid-In Capital	Stock Subscription Receivable	Other Comprehensive Income / Loss	Retained Earnings / Accumulated Deficit	Total
Balance, amount at Jan. 27, 2008	'	'	'	'	'	'
Common shares issued pursurant to share exchange agreement, shares	12,000,000	'	'	'	'	'
Common shares issued pursurant to share exchange agreement, amount	$12,000	'	'	'	'	$12,000
Common shares issued pursurant to recapitalization, shares	3,750,000	'	'	'	'	'
Common shares issued pursurant to recapitalization, amount	3,750	36,964	'	'	'	40,714
Common shares issued for cash, amount	'	36,964	'	'	'	'
Foreign currency translation adjustment	'	'	'	-810	'	-810
Net loss	'	'	'	'	-23,998	-23,998
Balance, amount at May. 31, 2008	15,750	36,964	'	-810	-23,998	27,906
Balance, shares at May. 31, 2008	15,750,000	'	'	'	'	'
Warrants issued with convertible debt	'	28,495	'	'	'	28,495
Foreign currency translation adjustment	'	'	'	1,295	'	1,295
Net loss	'	'	'	'	-333,982	-333,982
Balance, amount at May. 31, 2009	15,750	65,459	'	485	-357,980	-276,286
Balance, shares at May. 31, 2009	15,750,000	'	'	'	'	'
Common shares issued for cash, shares	120,000	'	'	'	'	'
Common shares issued for cash, amount	120	119,880	'	'	'	120,000
Foreign currency translation adjustment	'	'	'	-896	'	-896
Net loss	'	'	'	'	-743,192	-743,192
Balance, amount at May. 31, 2010	15,870	185,339	'	-411	-1,101,172	-900,374
Balance, shares at May. 31, 2010	15,870,000	'	'	'	'	'
Common shares issued for cash, shares	722,500	'	'	'	'	'
Common shares issued for cash, amount	723	721,777	'	'	'	722,500
Common shares issued to reduce debt, shares	25,000	'	'	'	'	'
Common shares issued to reduce debt, amount	25	24,975	'	'	'	25,000
Foreign currency translation adjustment	'	'	'	-2,112	'	-2,112
Net loss	'	'	'	'	-1,152,559	-1,152,559
Balance, amount at May. 31, 2011	16,618	932,091	'	-2,523	-2,253,731	-1,307,545
Balance, shares at May. 31, 2011	16,617,500	'	'	'	'	'
Common shares issued for cash, shares	520,000	'	'	'	'	'
Common shares issued for cash, amount	520	344,580	'	'	'	345,000
Common shares issued to reduce debt, shares	344,580	'	'	'	'	'
Common shares issued to reduce debt, amount	344	344,226	'	'	'	344,570
Stock subscriptions receivable, shares	170,002	'	'	'	'	'
Stock subscriptions receivable, amount	170	'	-170	'	'	'
Foreign currency translation adjustment	'	'	'	978	'	978
Net loss	'	'	'	'	-569,765	-569,765
Balance, amount at May. 31, 2012	17,652	1,620,797	-170	-1,545	-2,823,496	-1,186,762
Balance, shares at May. 31, 2012	17,652,082	'	'	'	'	'
Common shares issued for cash, shares	170,002	'	'	'	'	'
Common shares issued for cash, amount	170	84,831	'	'	'	85,001
Stock subscriptions receivable, shares	-170,002	'	'	'	'	'
Stock subscriptions receivable, amount	-170	'	170	'	'	'
Foreign currency translation adjustment	'	'	'	305	'	305
Net loss	'	'	'	'	-225,705	-225,705
Balance, amount at May. 31, 2013	$17,652	$1,705,628	'	($1,240)	($3,049,201)	($1,327,161)
Balance, shares at May. 31, 2013	17,552,082	'	'	'	'	'

Note_1_Summary_of_significant_

Note 1 – Summary of significant accounting policies	12 Months Ended
	31-May-13
Accounting Policies [Abstract]	'
Note 1 – Summary of significant accounting policies	'
	Note 1 – Summary of significant accounting policies
	This summary of significant accounting policies of PreAxia Health Care Payment Systems Inc. (the “Company”) is presented to assist in understanding the Company’s consolidated financial statements. The consolidated financial statements and notes are representations of the Company’s management who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the consolidated financial statements, which are stated in U.S. Dollars.
	Organization
	PreAxia Health Care Payment Systems Inc. (the “Company” OR “PreAxia”) was incorporated on April 3, 2000 in the State of Nevada. On May 31, 2005 the Company acquired all of the outstanding stock of Tiempo de Mexico Ltd. (“Tiempo”) in exchange for 5,000,000 shares of the common stock of the Company with a par value of $0.001. The Company had no operations prior to the date of the aforementioned acquisition.
	On May 30, 2008, the Company finalized the execution of an acquisition agreement dated April 22, 2008 (the “Acquisition Agreement”) between PreAxia, PreAxia Canada (formerly H Pay Card Inc.), Tiempo, Kimberley Coonfer (“Coonfer”), Caribbean Overseas Investments Ltd. (“Caribbean”) and the stockholders of PreAxia Canada (the “PreAxia Canada Stockholders”). Under the terms of the Acquisition Agreement, PreAxia acquired all of the issued and outstanding shares of PreAxia Canada resulting in PreAxia Canada becoming a direct, wholly-owned subsidiary of PreAxia. Upon the acquisition of PreAxia Canada by PreAxia, PreAxia issued the stockholders of PreAxia Canada an aggregate of 12,000,000 shares of the common stock of PreAxia. Pursuant to the terms of the Acquisition Agreement all of the issued and outstanding shares of the Company’s subsidiary, Tiempo (the “Tiempo Shares”) were transferred to Coonfer and Caribbean in exchange for the return of treasury of a total of 5,000,000 common shares of PreAxia (the “Cancellation Shares”). The Cancellation Shares were exchanged for the Tiempo Shares and $100,000 of the intercompany debt between Tiempo and PreAxia was written off on the books of Tiempo and PreAxia, and Tiempo provided a promissory note for the remaining intercompany debt between Tiempo and PreAxia in the amount of $49,281. As of May 30, 2008, Tiempo is no longer a subsidiary of PreAxia, PreAxia Canada Inc. is a wholly-owned subsidiary of PreAxia. PreAxia Canada Inc. Stockholders received an aggregate of 12,000,000 shares of PreAxia’s common stock representing 78.7% of the issued and outstanding shares of the Company. Tom Zapatinas, an Officer and Director of PreAxia Health Care Payment Systems Inc., is also an Officer and Director of PreAxia Canada Inc. He disclosed such information and interest in this transaction to the Board of Directors prior to the conclusion of this transaction.
	As a result, the consolidated results of operations presented at May 31, 2013 are those of the Company and PreAxia Canada Inc. PreAxia Canada Inc. was incorporated pursuant to the laws of the Province of Alberta on January 28, 2008. Since inception of PreAxia Canada Inc., its business objective has been the development, distribution, marketing and sale of health care payment processing services and products.
	Nature and Continuance of Operations
	The Company is in the development stage and has not yet realized any revenues from its planned operations.
	The primary operations of the Company will eventually be undertaken by PreAxia Canada. PreAxia Canada is in the process of developing an online access system creating a health savings account that allows card payments and processing services to third-party administrators, insurance companies and others.
	These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these consolidated financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. At May 31, 2013, the Company had not yet achieved profitable operations, has accumulated losses of $3,049,201 since inception, has negative working capital of $1,429,313 and expects to incur further losses in the development of its business, all of which raises substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern but believes the Company will be able to obtain additional funds by equity financing and/or related party advances, however there is no assurance of additional funding being available.
	Use of Estimates in the preparation of the consolidated financial statements
	The preparation of the Company's consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
	Cash and Cash Equivalents
	The Company considers all highly liquid debt instruments with an original maturity of three months or less to be cash equivalents.
	Foreign Currency Translation
	The functional currency of the Company is the United States dollar. The functional currency of PreAxia Canada is the Canadian dollar. Assets and liabilities in the accompanying consolidated financial statements are translated into United States dollars at the exchange rate in effect at the balance sheet date and capital accounts are translated at historical rates. Income statement accounts are translated at the average rates of exchange prevailing during the period. Translation adjustments arising from the use of differing exchange rates from period to period are included in the accumulated other comprehensive income (loss) account in stockholders’ deficit.
	Transactions undertaken in currencies other than the functional currency of the entity are translated using the exchange rate in effect as of the transaction date. Any exchange gains and losses are included in the Statement of Operations and Comprehensive Loss.
	Development Stage Company
	The Company is devoting substantially all of its present efforts to establish a new business and none of its planned principal operations have commenced. All losses accumulated since inception has been considered as part of the Company’s development stage activities.
	Gain (Loss) Per Share
	Gain (loss) per share of common stock is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
	Research and Development Costs
	Research and development costs are expensed in the year in which they are incurred.
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation.
	Reclassification
	The consolidated financial statements for the year ended May 31, 2010 has been reclassified from statements previously presented for comparative purposes. This includes payables – related parties, comprehensive income disclosure of foreign currency and several items in statement of cash flows, which required the removal of the repayment of loan payable – related party, the removal of proceeds from loan payable, an increase to the proceeds from loans payable – related party and an increase of accounts payable – related party.

Note_2_Recent_Accounting_Prono

Note 2 – Recent Accounting Pronouncements	12 Months Ended
	31-May-13
Accounting Changes and Error Corrections [Abstract]	'
Note 2 – Recent Accounting Pronouncements	'
	Note 2 – Recent Accounting Pronouncements
	In June 2009, the FASB established the Accounting Standards Codification (“Codification” or “ASC”) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of consolidated financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our consolidated financial statements. The ASC does change the way the guidance is organized and presented.
	In January 2010, the FASB issued Accounting Standards Update No. 2010-06, Improving Disclosures about Fair Value Measurements (Topic 820)—Fair Value Measurements and Disclosures (ASU 2010-06), to add additional disclosures about the different classes of assets and liabilities measured at fair value, the valuation techniques and inputs used, the activity in Level 3 fair value measurements, and the transfers between Levels 1, 2, and 3. The Company is currently evaluating the impact of the pending adoption of this standards update on its consolidated financial statements. The new disclosures and clarifications of existing disclosure are effective for fiscal years beginning after December 15, 2009, except for the disclosure requirements related to the purchases, sales, issuances and settlements in the roll-forward activity of Level 3 fair value measurements. Those disclosure requirements are effective for fiscal years ending after December 31, 2010. The adoption of ASU 2010-06 had no material impact on the Company’s financial statements.
	In April 2010, the FASB issued Accounting Standards Update No. 2010-17, Revenue Recognition—Milestone Method (Topic 605) – Revenue Recognition (ASU 2010-17). ASU 2010-17 provides guidance on defining the milestone and determining when the use of the milestone method of revenue recognition for research or development transactions is appropriate. It provides criteria for evaluating if the milestone is substantive and clarifies that a vendor can recognize consideration that is contingent upon achievement of a milestone as revenue in the period in which the milestone is achieved, if the milestone meets all the criteria to be considered substantive. ASU 2010-17 is effective for the Company in fiscal 2011 and should be applied prospectively. Early adoption is permitted. The Company is currently evaluating the impact of the pending adoption of ASU 2010-17 on its consolidated financial statements.
	Other
	The Company has selected May 31 as its year-end and the Company paid no dividends in 2013.
	Going Concern
	The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As shown in the accompanying consolidated financial statements, the Company has incurred cumulative net losses of ($3,049,201) since inception, and currently has no sales. The future of the Company is dependent upon its ability to obtain financing and upon future profitable operations from the design, development and commercialization of its health care payment processing services and products. Management has plans to seek additional capital through private placements of its common stock. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

Note_3_Related_Party_Transacti

Note 3 – Related Party Transactions	12 Months Ended
	31-May-13
Related Party Transactions [Abstract]	'
Note 3 – Related Party Transactions	'
	Note 3 – Related Party Transactions
	Accounts Payable
	During the year ended May 31, 2013, the Company’s president, Tom Zapatinas, invoiced $120,000 for management services rendered to the Company for the period June 1, 2012 to May 31, 2013. As at May 31, 2013, Accounts payable – related party includes a total of $732,202 due and payable to Mr. Zapatinas. There are no terms of repayment for this payable.
	Lizée Gauthier, Certified General Accountants, as at May 31, 2013, held an accounts payable – related party totalling $84,892 due and payable to Mr. Lizée. There are no terms of repayment for this payable.
	As of May 31, 2013, the Company owed shareholders $459,786. The terms of repayment are 30 days after demand is made by the shareholder.
	Loans Payable
	The Company had a loan payable to a shareholder of the Company in the amount of $68,635. The loan was unsecured, with 6% interest per annum and was payable 30 days after demand is made by the shareholder. As of May 31, 2013 the Company had accrued interest on the related party loan in the amount of $9,043.

Note_4_Income_Taxes

Note 4 – Income Taxes	12 Months Ended
	31-May-13
Income Tax Disclosure [Abstract]	'
Note 4 – Income Taxes	'
	Note 4 – Income Taxes
	As at May 31, 2013, the Company is in arrears on filing its statutory income tax returns. The Company has incurred substantial net operating losses for financial statement purposes in excess of $3,000,000 since January 28, 2008 (Date of Inception) or net losses for tax purposes of $2,704,138.
	It is management’s intention to hire a tax professional to file these tax returns on its behalf.
	The company’s deferred tax assets and liabilities consist primarily of the following:
			2013			2012
	Net operating losses – U.S. parent:
	Amount carried forward from prior years	$	-1,035,748		$	(212,754	)
	Net operating losses		(80,692	)		(822,994	)
			(1,116,440	)		(1,035,748	)
	Net operating losses – Canadian subsidiary:
	Amount carried forward from prior years		-25,652			(25,406	)
	Net operating losses		(3,608	)		(246	)
			(29,260	)		(25,652	)
	Total		(1,145,700	)		(1,061,400	)
	Less: valuation allowance		1,145,700			1,061,400
		$	-		$	-
	During the years ended May 31, 2013 and 2012, the change in valuation allowance was $ 84,300 and $213,000, respectively.

Note_5_Contingencies

Note 5 – Contingencies	12 Months Ended
	31-May-13
Commitments and Contingencies Disclosure [Abstract]	'
Note 5 – Contingencies	'
	Note 5 – Contingencies
	From time to time the Company may be a party to litigation matters involving claims against the Company.  Management believes that there are no current matters that would have a material effect on the Company’s financial position or results of operations.  At May 31, 2013, a subsidiary of the Company was in negotiations with a vendor on an amount outstanding.  Management believes any settlement will not materially affect the financial position of the company.

Note_6_Subsequent_events

Note 6 - Subsequent events	12 Months Ended
	31-May-13
Subsequent Events [Abstract]	'
Note 6 - Subsequent events	'
	Note 6 - Subsequent events
	The Company does not have any additional subsequent events as of the date this report was issued.

Note_1_Summary_of_significant_1

Note 1 – Summary of significant accounting policies (Policies)	12 Months Ended
	31-May-13
Accounting Policies [Abstract]	'
Nature and Continuance of Operations	'
	Nature and Continuance of Operations
	The Company is in the development stage and has not yet realized any revenues from its planned operations.
	The primary operations of the Company will eventually be undertaken by PreAxia Canada. PreAxia Canada is in the process of developing an online access system creating a health savings account that allows card payments and processing services to third-party administrators, insurance companies and others.
	These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these consolidated financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. At May 31, 2013, the Company had not yet achieved profitable operations, has accumulated losses of $3,049,201 since inception, has negative working capital of $1,429,313 and expects to incur further losses in the development of its business, all of which raises substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern but believes the Company will be able to obtain additional funds by equity financing and/or related party advances, however there is no assurance of additional funding being available.
	Use of Estimates in the preparation of the consolidated financial statements
	The preparation of the Company's consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid debt instruments with an original maturity of three months or less to be cash equivalents.
Foreign Currency Translation	'
	Foreign Currency Translation
	The functional currency of the Company is the United States dollar. The functional currency of PreAxia Canada is the Canadian dollar. Assets and liabilities in the accompanying consolidated financial statements are translated into United States dollars at the exchange rate in effect at the balance sheet date and capital accounts are translated at historical rates. Income statement accounts are translated at the average rates of exchange prevailing during the period. Translation adjustments arising from the use of differing exchange rates from period to period are included in the accumulated other comprehensive income (loss) account in stockholders’ deficit.
	Transactions undertaken in currencies other than the functional currency of the entity are translated using the exchange rate in effect as of the transaction date. Any exchange gains and losses are included in the Statement of Operations and Comprehensive Loss.
Development Stage Company	'
	Development Stage Company
	The Company is devoting substantially all of its present efforts to establish a new business and none of its planned principal operations have commenced. All losses accumulated since inception has been considered as part of the Company’s development stage activities.
Gain (Loss) Per Share	'
	Gain (Loss) Per Share
	Gain (loss) per share of common stock is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Research and Development Costs	'
	Research and Development Costs
	Research and development costs are expensed in the year in which they are incurred.
Principles of Consolidation	'
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation.
Reclassification	'
	Reclassification
	The consolidated financial statements for the year ended May 31, 2010 has been reclassified from statements previously presented for comparative purposes. This includes payables – related parties, comprehensive income disclosure of foreign currency and several items in statement of cash flows, which required the removal of the repayment of loan payable – related party, the removal of proceeds from loan payable, an increase to the proceeds from loans payable – related party and an increase of accounts payable – related party.

Note_2_Recent_Accounting_Prono1

Note 2 – Recent Accounting Pronouncements (Policies)	12 Months Ended
	31-May-13
Accounting Changes and Error Corrections [Abstract]	'
Going Concern	'
	Going Concern
	The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As shown in the accompanying consolidated financial statements, the Company has incurred cumulative net losses of ($3,049,201) since inception, and currently has no sales. The future of the Company is dependent upon its ability to obtain financing and upon future profitable operations from the design, development and commercialization of its health care payment processing services and products. Management has plans to seek additional capital through private placements of its common stock. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

Note_4_Income_Taxes_Tables

Note 4 – Income Taxes (Tables)	12 Months Ended
	31-May-13
Income Tax Disclosure [Abstract]	'
Deferred tax table	'
			2013			2012
	Net operating losses – U.S. parent:
	Amount carried forward from prior years	$	-1,035,748		$	(212,754	)
	Net operating losses		(80,692	)		(822,994	)
			(1,116,440	)		(1,035,748	)
	Net operating losses – Canadian subsidiary:
	Amount carried forward from prior years		-25,652			(25,406	)
	Net operating losses		(3,608	)		(246	)
			(29,260	)		(25,652	)
	Total		(1,145,700	)		(1,061,400	)
	Less: valuation allowance		1,145,700			1,061,400
		$	-		$	-

Note_3_Related_Party_Transacti1

Note 3 - Related Party Transactions (Narrative Details) (USD $)	31-May-13	31-May-12
Loan payable accrued interest	$8,992	$5,326
Related party	'	'
Accounts payable related party	459,786	459,786
Account payable for accounting services	84,892	84,892
Loan payable	68,635	'
Loan payable accrued interest	9,043	'
Interest rate	6.00%	'
Tom Zapatinas	'	'
Accounts payable related party	$732,202	'

Note_4_Income_Taxes_Narrative_

Note 4 - Income Taxes (Narrative Details) (USD $)	12 Months Ended
	31-May-13	31-May-12
Total	($1,145,700)	($1,061,400)
Valuation allowance	1,145,700	1,061,400
Change in valuation allowance	84,300	213,000
Canadian Subsidiary [Member]	'	'
Amount carried forward from prior years	-25,652	-25,406
Net operating losses	-3,608	-246
US Parent [Member]	'	'
Amount carried forward from prior years	-1,035,748	-212,754
Net operating losses	($80,692)	($822,994)